Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways

E-ISSN： 1875-6190|15|4|620-636

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.15, Iss.4, 2017-04, pp. : 620-636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peripheral metabotropic glutamate receptors as drug targets for pain relief

By Carlton Susan M Neugebauer Volker

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 349-361

Informa Healthcare

Access to resources Recommend Favorite

Potassium Channels in Peripheral Pain Pathways: Expression, Function and Therapeutic Potential

Current Neuropharmacology, Vol. 11, Iss. 6, 2013-01 ,pp. : 621-640

Bentham Science Publishers

Access to resources Recommend Favorite

Acetylation Control of Cancer Cell Metabolism

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2627-2633

Bentham Science Publishers

Access to resources Recommend Favorite

Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non-small Cell Lung Cancer

Current Cancer Drug Targets, Vol. 12, Iss. 2, 2012-02 ,pp. : 107-123

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson’s Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 3, 2015-04 ,pp. : 313-324

Bentham Science Publishers

Access to resources Recommend Favorite